Every Form 4 that Herbalife Ltd. (HLF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HLF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLF filings page.
HERBALIFE LTD. Chief Commercial Officer Frank Lamberti reported a tax-withholding disposition of 1,710 shares of common stock on August 4, 2026, at $12.80 per share to satisfy tax obligations from vesting restricted stock units granted August 4, 2023. After this withholding, he directly holds 34,914 shares of common stock.
HERBALIFE LTD. director Sophie L'Helias reported an open-market purchase of common stock. She bought 1,200 shares of Herbalife common stock on June 4, 2026 at a price of $11.31 per share. After this transaction, she directly owns 79,882 shares of the company’s common stock.
HERBALIFE LTD. Chief Operating Officer Troy Hicks reported multiple stock transactions involving common shares. On May 18, 2026, he exercised stock appreciation rights covering 83,270 shares at exercise prices of $9.58 and $8.31 per share, converting these awards into common stock.
On the same date, a total of 72,626 shares were disposed of to cover tax obligations at a reported price of $12.59 per share. Hicks also conducted open-market sales of 38,377 shares on May 18 at a weighted average price of $12.9325 per share and 10,000 shares on May 19 at a weighted average price of $12.3245 per share.
Following these transactions, Hicks directly owned 9,706 shares of Herbalife common stock. The filing notes that the sale prices were weighted averages for trades executed within stated price ranges.
HERBALIFE LTD. Chief Commercial Officer Frank Lamberti reported selling a total of 142,919 shares of common stock in open-market transactions. On May 12, 2026, he sold 134,982 shares at $13.50 per share, and on May 11, 2026, he sold 7,937 shares at a weighted average price of $13.8594 per share.
The filing notes that the 7,937-share sale occurred in multiple trades at prices ranging from $13.85 to $13.8601 per share. Following these sales, Lamberti directly holds 36,624 shares of Herbalife common stock.
Cloud Lynda reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Lynda Cloud received an equity award of 11,879 shares of Common Stock in the form of restricted stock units. The grant carried a price of $0.00 per share as it is compensation, not an open-market purchase. These RSUs will vest 100% on April 15, 2027, if she continues serving on the Board through that date, and her direct holdings after the award total 50,736 shares.
Otero Maria reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Maria Otero received a grant of 11,879 restricted stock units (RSUs) of common stock as compensation, at no cash purchase price. These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, if she continues to serve on the Board through that date. Following this grant and the inclusion of 3,200 shares previously omitted from earlier reports, Otero now holds 95,129 shares of Herbalife common stock directly.
Carmona Richard H reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Richard H. Carmona received a grant of 11,879 shares of Common Stock in the form of restricted stock units. These RSUs were granted at no cash cost and increase his direct holdings to 83,645 shares after the transaction.
The RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. They will vest 100% on April 15, 2027, provided Carmona continues to serve on the company’s Board of Directors through that date.
LEVITT MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Michael J. Levitt received an equity grant in the form of 11,879 restricted stock units (RSUs) on May 8, 2026. The award was granted at no cash cost per unit and was made under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, as long as Levitt continues to serve on the Board of Directors through that date. After this grant, his directly held equity position reported in this filing totals 49,393 shares or units of common stock-based holdings.
Mendoza Juan Miguel reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Juan Miguel Mendoza received a grant of 11,879 shares of common stock in the form of restricted stock units (RSUs). The award was granted at no cash cost per share and is part of his equity compensation.
The RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, as long as he continues serving on the company’s Board of Directors through that date. After this grant, Mendoza holds a total of 181,879 shares of common stock directly.
Walsh Des reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Des Walsh received an equity grant of 11,879 shares of Common Stock in the form of restricted stock units under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These RSUs carry no cash purchase price.
The RSUs will vest 100% on April 15, 2027, as long as Walsh continues to serve on the company’s Board of Directors through that date. After this award, he holds 61,879 shares directly and 200,000 shares indirectly through a trust.
HERBALIFE LTD. director Rodica Macadrai received a grant of 11,879 shares of Common Stock in the form of restricted stock units as compensation. The award carries no cash exercise price. After this grant, she directly holds 67,441 shares in total.
The restricted stock units were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest 100% on April 15, 2027, provided she continues to serve on the Board of Directors through that date.
Mulligan Donal L reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Donal L. Mulligan reported an equity award. He received 11,879 shares of Common Stock in the form of restricted stock units granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan at no cash cost.
The RSUs will vest 100% on April 15, 2027, if he continues to serve on the Board through that date. After this grant, he directly holds 68,982 shares of Common Stock and also has an indirect holding of 60,000 shares held by a trust.
L'Helias Sophie reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. director Sophie L’Helias reported receiving an equity award of 11,879 shares of Common Stock in the form of restricted stock units (RSUs) at no cash cost. These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The RSUs will vest 100% on April 15, 2027, if she continues serving on the Board of Directors through that date. After this grant, she reports beneficial ownership of 78,682 shares of Common Stock, reflecting her total direct position as of this filing.
Miller Perkins reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. director Miller Perkins reported receiving 13,626 shares of Common Stock in the form of restricted stock units (RSUs). These RSUs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and carry a grant price of $0.00 per share.
The RSUs will vest 100% on April 15, 2027, provided Perkins continues to serve on the company’s Board of Directors through that date. After this grant, Perkins directly holds 50,769 shares of Herbalife common stock.
HERBALIFE LTD. president Robert Levy reported routine share dispositions to cover tax obligations on vested equity awards. On May 3, 2026 and May 4, 2026, a total of 4,904 common shares were withheld by the company at prices around $16 per share to satisfy taxes on restricted stock units that vested from grants made in 2023 and 2024. Following these non‑market transactions, Levy held 11,405 common shares directly and 433,049 common shares indirectly through a trust.
HERBALIFE LTD. Chief Executive Officer Stephan Paulo Gratziani reported a tax-related share disposition on Common Stock. On May 3, 2026, 7,873 shares were withheld at $16.28 per share to satisfy tax obligations from vesting restricted stock units. After this withholding, he directly holds 107,310 shares. This was not an open-market sale but an automatic tax-withholding transaction tied to equity compensation.
HERBALIFE LTD. Chief Operating Officer Troy Hicks reported routine share dispositions related to tax withholding on vested equity awards. On May 3 and May 4, 2026, a total of 6,214 shares of common stock were withheld at prices of $16.28 and $15.82 per share.
The footnotes explain these shares were withheld to satisfy tax obligations triggered by the vesting of restricted stock units granted on May 3, 2024 and May 4, 2023. After these transactions, Hicks continued to hold over 44,000 shares of Herbalife common stock directly.
HERBALIFE LTD. Chief Legal Officer Henry C. Wang reported routine share dispositions related to tax withholding, not open-market sales. On two consecutive days, shares of common stock were withheld to cover taxes triggered by the vesting of previously granted restricted stock units.
In total, 10,562 shares were withheld for tax obligations tied to RSUs granted in 2023 and 2024. After these transactions, Wang directly holds 142,514 shares of Herbalife common stock, including 4,099 shares acquired earlier through the company’s Employee Stock Purchase Plan.
HERBALIFE LTD. senior vice president and chief accounting officer Jehangir D. Irani reported routine share dispositions to cover tax obligations on vested equity awards. On May 3 and May 4, 2026, a total of 9,053 common shares were withheld as tax-withholding dispositions tied to restricted stock units granted in 2023 and 2024. These are not open-market sales but shares withheld by the company to pay taxes on vesting. After these transactions, Irani directly holds 46,371 Herbalife common shares.
HERBALIFE LTD. Chief Commercial Officer Frank Lamberti reported routine tax-related share dispositions tied to restricted stock unit vesting. On May 3 and May 4, 2026, a total of 8,224 Common Stock shares were withheld at prices of $16.28 and $15.82 per share to satisfy tax obligations. After these non-market transactions, he directly holds 179,543 shares of Herbalife common stock.
Herbalife Ltd. Chief Financial Officer John DeSimone reported the grant of 45,195 stock appreciation rights (SARs) on February 25, 2026 under the company’s Amended and Restated 2023 Stock Incentive Plan. This amended filing corrects the SARs’ exercise price, which was previously reported incorrectly.
The SARs vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, subject to Mr. DeSimone’s continued service through each vesting date. No other information from the original Form 4 was changed.
Herbalife Ltd. reported that Chief Commercial Officer Frank Lamberti acquired 40,437 stock appreciation rights (SARs) on February 25, 2026 under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
The SARs vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, conditioned on his continued service through each vesting date. This amended Form 4 was filed solely to correct the SAR exercise price, which was previously reported as $10.51, with no other changes to the original report.
Herbalife Ltd. Executive Chairman Michael Johnson reported an amended insider filing reflecting equity awards granted on February 25, 2026. He was granted 399,619 stock appreciation rights and 72,689 restricted stock units under the Amended and Restated 2023 Stock Incentive Plan. Both the SARs and RSUs vest in two equal installments, 50% on February 25, 2027 and 50% on February 25, 2028, contingent on continued service. The amendment states it was filed solely to correct a previously reported exercise price; no other information from the original Form 4 was changed.
HERBALIFE LTD. Chief Legal Officer Henry C. Wang reported an amended Form 4 reflecting a grant of 33,301 stock appreciation rights. The amendment corrects a previously reported exercise price of $10.51. These SARs were granted under the company’s Amended and Restated 2023 Stock Incentive Plan and will vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service.
HERBALIFE LTD. President Robert Levy reported an amended insider transaction reflecting a grant of stock appreciation rights. The Form 4/A shows an acquisition of 33,301 stock appreciation rights at an exercise price of $0.00 per right, classified as a grant or award.
The amendment states it was filed solely to correct the previously reported exercise price, which had been shown as $10.51, with no other changes to the original filing. These stock appreciation rights were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, subject to Mr. Levy’s continued service.
HERBALIFE LTD. Chief Operating Officer Troy Hicks filed an amended insider report reflecting a prior grant of 33,301 stock appreciation rights (SARs). The amendment is solely to correct the exercise price previously reported as $10.51; all other details remain unchanged. The SARs were granted under the Amended and Restated 2023 Stock Incentive Plan and will vest in three equal installments on February 25, 2027, 2028, and 2029, subject to his continued service.
HERBALIFE LTD. Chief Executive Officer Stephan Paulo Gratziani reported an amended Form 4 reflecting a prior grant of stock appreciation rights. The amendment is filed solely to correct the exercise price, which had previously been reported as $10.51. The CEO holds 215,033 stock appreciation rights granted on February 25, 2026, under the Amended and Restated 2023 Stock Incentive Plan. These rights vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, contingent on continued service, and represent non-cash equity-based compensation rather than an open-market share purchase or sale.
LEVY ROBERT reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. reported that President Robert Levy received a grant of 33,301 stock appreciation rights (SARs) on February 25, 2026 under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These derivative awards were granted at a price of $0.00 per right as part of his compensation.
The SARs will vest in three equal installments, with one-third vesting on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to his continued service through each vesting date. Following this grant, he directly holds 33,301 SARs.
Lamberti Frank reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd. Chief Commercial Officer Frank Lamberti received a grant of 40,437 stock appreciation rights (SARs) on February 25, 2026 under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs were awarded at a price of $0.00 per right.
The SARs vest in three equal installments, with one-third vesting on February 25, 2027, one-third on February 25, 2028, and the final one-third on February 25, 2029, subject to Mr. Lamberti’s continued service through each vesting date. Following this grant, he holds 40,437 SARs directly.
JOHNSON MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. Executive Chairman Michael Johnson reported equity awards rather than open-market trades. On February 25, 2026, he was granted 399,619 stock appreciation rights at $0.00 per share and 72,689 restricted stock units representing common stock.
Both the RSUs and SARs were granted under the company’s stock incentive plan and vest in two equal installments: 50% on February 25, 2027 and 50% on February 25, 2028, subject to continued service. Following these awards, his direct common stock holdings reported total 887,415 shares.
Hicks Troy reported acquisition or exercise transactions in this Form 4 filing.
Herbalife Ltd.'s Chief Operating Officer, Troy Hicks, received a grant of 33,301 stock appreciation rights (SARs) on February 25, 2026. These SARs were issued at a price of $0.00 per right and increase in value if the company’s stock price rises.
The award was granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. The SARs will vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, as long as Hicks continues in service through each vesting date.
Gratziani Stephan Paulo reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. Chief Executive Officer Stephan Paulo Gratziani reported receiving a grant of 215,033 stock appreciation rights on February 25, 2026. These rights were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan as equity-based compensation.
The stock appreciation rights will vest in one-third increments on February 25, 2027, February 25, 2028, and February 25, 2029, and each installment is subject to his continued service with the company through the applicable vesting date.
DeSimone John reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. Chief Financial Officer John DeSimone received a grant of 45,195 stock appreciation rights under the Amended and Restated 2023 Stock Incentive Plan. These rights were granted at a price of $0.00 per right and will vest in three equal installments on February 25 of 2027, 2028, and 2029, contingent on his continued service with the company.
Wang Henry C reported acquisition or exercise transactions in this Form 4 filing.
HERBALIFE LTD. Chief Legal Officer Henry C. Wang received a grant of 33,301 stock appreciation rights under the company’s Amended and Restated 2023 Stock Incentive Plan. These SARs vest in three equal installments on February 25, 2027, 2028, and 2029, conditioned on continued service.
HERBALIFE LTD. Chief Executive Officer Stephan Paulo Gratziani reported a tax-related share disposition. On February 16, 2026, 3,664 shares of common stock were withheld at $15.90 per share to cover tax obligations triggered by the vesting of previously granted restricted stock units. After this withholding, Gratziani directly owned 115,183 common shares.
HERBALIFE LTD. Chief Financial Officer John DeSimone reported a tax-withholding share disposition related to vested equity awards. On this Form 4, 17,382 shares of common stock were withheld at $15.90 per share to cover tax obligations from restricted stock units vesting, leaving him with 241,144 directly owned shares.
Herbalife Ltd. director reports open-market stock purchases
A director of Herbalife Ltd. (HLF), Sophie L'Helias, reported buying common stock in two open-market transactions. On November 26, 2025, she purchased 400 shares of Herbalife common stock at a price of $13.22 per share. On December 1, 2025, she bought an additional 800 shares at $12.70 per share. After these transactions, she directly beneficially owns 66,803 shares of Herbalife common stock. The filing is reported on a Form 4 for a single reporting person.
Herbalife Ltd. (HLF) director Lynda Cloud reported an open market purchase of the company’s common stock. On 11/18/2025, she bought 17,000 shares at a weighted average price of $8.97 per share, through multiple trades within a price range of $8.93 to $9.01. After this transaction, she beneficially owns 38,857 shares of Herbalife common stock in direct ownership.
Herbalife Ltd. (HLF) reported an equity-based compensation transaction for its Chief Commercial Officer on a Form 4. On November 14, 2025, the officer received 15,182 stock appreciation rights (SARs) under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan, each with an exercise price of $9.23 and linked to one share of common stock. These SARs became exercisable on November 14, 2025 and will expire on November 14, 2035. They are scheduled to vest in three equal one-third installments on November 14, 2026, November 14, 2027, and November 14, 2028, provided the executive continues in service through each vesting date.
Herbalife Ltd. (HLF) disclosed an insider transaction by its Chief Executive Officer via Form 4. On 11/03/2025, 3,463 shares of common stock were withheld to satisfy taxes due upon the vesting of previously granted restricted stock units. The transaction was coded “F,” indicating tax withholding, at a price of $8.07 per share.
Following this administrative withholding, the CEO directly beneficially owns 118,847 shares.